SAT was established to develop, manufacture and market cardiac-related medical devices that addresses the need of up to 75 million Rheumatic Heart Disease patients worldwide.
It is our mission to make life-saving, cost-effective cardiac devices and deployment systems available to sufferers of heart disease in developing countries. The founders of SAT are internationally renowned experts in both medical device development and their surgical implantation.
SAT is a start-up with support from the University of Cape Town. Its concepts have evolved from research done at the University and the pioneering Chris Barnard Department of Cardiothoracic Surgery at Groote Schuur Hospital.
Learn more about our Challenge.